Showing results (391-400 of 579) with videos related to
Sort By:
Pageof 58
Signal Transduction and Targeted Therapy|September 15, 2022
Dendritic cell-derived IL-27 p28 regulates T cell program in pathogenicity and alleviates acute graft-versus-host diseaseHuanle Gong, Shoubao Ma, Jia Chen, et al.Annals of Hematology|January 12, 2023
Autologous stem cell transplantation in multiple myeloma patients with renal impairmentYingying Zhai, Lingzhi Yan, Song Jin, et al.JCI Insight|May 4, 2018
Prediction of acute GVHD and relapse by metabolic biomarkers after allogeneic hematopoietic stem cell transplantationXiaojin Wu, Yiyu Xie, Chang Wang, et al.Experimental Hematology & Oncology|June 2, 2022
IL-39 promotes chronic graft-versus-host disease by increasing T and B Cell pathogenicityKangkang Lv, Bo Hu, Mingzhu Xu, et al.Advances in Therapy|April 23, 2020
Pharmacokinetics and Safety of Posaconazole Tablet Formulation in Chinese Participants at High Risk for Invasive Fungal InfectionKaiyan Liu, Depei Wu, Junmin Li, et al.Frontiers in Immunology|December 17, 2020
IL-Y Aggravates Murine Chronic Graft-<i>Versus</i>-Host Disease by Enhancing T and B Cell ResponsesLi Wan, Ziqi Jin, Bo Hu, et al.Frontiers in Immunology|September 22, 2022
Severe aplastic anemia patients with infection who received an allogeneic hematopoietic stem cell transplantation had a better chance: Long-term outcomes of a multicenter studyLimin Liu, Miao Miao, Hailong He, et al.Annals of Hematology|May 1, 2026
CD135 (FLT3 receptor) expression as an indicator of prognosis in patients with de novo acute myeloid leukemiaJinhong Nie, Lu Gao, Yingchun Shao, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 21, 2019
Radiation Priming Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma With High Tumor BurdenChangju Qu, Nana Ping, Liqing Kang, et al.American Journal of Hematology|March 7, 2023
Conditioning therapy with N-acetyl-L-cysteine, decitabine and modified BUCY regimen for myeloid malignancies patients prior to allogeneic hematopoietic stem cell transplantationYaqiong Tang, Ziyan Zhang, Silu Liu, et al.Pageof 58